Physician profile
Marcial Serrano
NPI 1053358135
$1,499.24
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $864 · 2020: $612 · 2021: $23.79.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $262.61 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $217.06 | 2019-2020 | |
| Alkermes, INC. | $192.40 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $143.33 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $140.71 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $120.69 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $99.78 | 2019-2020 | |
| Allergan, INC. | $83.93 | 2019-2020 | |
| Shire North American Group INC | $62.81 | 2019 | |
| Orexo US, INC. | $47.08 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $44.26 | 2020 | |
| Abbvie INC. | $23.79 | 2021 | |
| Jazz Pharmaceuticals INC. | $16.90 | 2019 | |
| Neurocrine Biosciences, INC. | $15.59 | 2020 | |
| Tris Pharma INC | $14.64 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuronetics, INC. | $13.66 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcial Serrano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.